Leading the Charge

We’ve built a company poised to produce transformative pharmaceutical solutions by bringing together leaders steeped in all the functional areas needed to bring new drugs to life. With a deeply skilled management team directing our day-to-day wins, and a Board with a stellar track record, we’re acquiring, developing and commercializing drug candidates for diseases where there is a high unmet medical need.

Meet Our Best & Brightest

Bringing products to market for patients with high unmet medical need. Managing quality and regulatory compliance for a global biotech company. Overseeing clinical development for top-flight pharmaceutical companies. These are the back stories of just some of the bright minds you’ll find in the lab, meeting room and beyond at Dova Pharmaceuticals.

Kevin Laliberte

Kevin Laliberte, PharmD
Senior Vice President, Product Development

Dr. Laliberte joined Dova as Sr. Vice President, Product Development in March 2017, with responsibility for management of the clinical and pharmaceutical development as well as commercial supply chain functions. From 2003 until 2017, Dr. Laliberte held roles of increasing responsibility at United Therapeutics Corporation (NASDAQ: UTHR), including Sr. Vice President Product Development and Clinical Operations where he was responsible for all development activities (preclinical through Phase 4) including preparation of regulatory submissions. Dr. Laliberte received a Pharm.D. from the University of Michigan and completed a drug development fellowship at the University of North Carolina School of Pharmacy and GlaxoSmithKline.